Hickory, North Carolina Clinical Trials

A listing of Hickory, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 26 clinical trials
featured
CAHtalyst Study: A Research Study for Adults with Classic Congenital Adrenal Hyperplasia (CAH)

The CAHtalyst Study is a clinical research study evaluating an investigational medication for adults 18 years of age and older who have been diagnosed with classic congenital adrenal hyperplasia (CAH). The investigational medication is an oral capsule that will be taken twice daily with breakfast and evening meals. All participants who …

congenital adrenal hyperplasia
classic congenital adrenal hyperplasia
OnSite Clinical Solutions
 (0.7 away) Contact site
  • 30 views
  • 23 Nov, 2020
  • 1 location
featured
Elevated Lipid Levels on Statin

A research study is evaluating an investigational medication combined with statin for adults with elevated lipids.

PMG Research of Hickory
 (0.0 away) Contact site
  • 0 views
  • 23 Nov, 2020
  • 1 location
featured
Moderate to Severe Rheumatoid Arthritis (RA)

Adults with rheumatoid arthritis have an increased risk of blood clots. This research study is comparing the risk of blood clots among patients treated with certain study medications.  

PMG Research of Hickory
 (0.0 away) Contact site
  • 10 views
  • 23 Nov, 2020
  • 1 location
A Study of TAK-994 in Adults With Narcolepsy

Adults with narcolepsy who have completed the TAK-994-1501 study will be able to take part in this study. The main aim of this study is to check if participants have side effects from TAK-994. Participants will take one of 3 different TAK-994 dose for 8 weeks. Then, half the participants …

Research Carolina Elite, LLC,
 (0.6 away) Contact site
  • 8 views
  • 07 Jul, 2021
  • +151 other locations
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia

This is a Phase 3 study to evaluate the efficacy, safety, and tolerability of crinecerfont versus placebo administered for 24 weeks in approximately 165 adult subjects with classic CAH due to 21-hydroxylase deficiency. The study consists of a 6 month randomized, double blind, placebo-controlled period, followed by 1 year of …

deficiency
21-ohd
Neurocrine Clinical Site
 (0.6 away) Contact site
  • 94 views
  • 26 Jul, 2021
  • +43 other locations
CLE-100 as an Oral Therapy in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

The clinical trial is a Phase 2, double-blind, randomized, placebo controlled study in Major Depressive Disorder (MDD) participants currently treated with antidepressant therapy. The objective of the study is to assess CLE-100 for the treatment of MDD in participants currently treated with standard antidepressant therapy.

Clinical Site 111
 (0.6 away) Contact site
  • 2 views
  • 02 Aug, 2021
  • +26 other locations
A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH

An investigation of the efficacy and safety of up to 52 weeks of treatment with Tildacerfont in subjects with classic CAH who have elevated biomarkers at baseline on their current GC regimen.

17-hydroxyprogesterone
deficiency
21-ohd
Spruce Study Site
 (0.6 away) Contact site
  • 7 views
  • 29 Jun, 2021
  • +26 other locations
A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH

An investigation of the ability of Tildacerfont to reduce supraphysiologic glucocorticoid dosing in classic CAH subjects over 52 weeks of treatment.

deficiency
21-ohd
Spruce Study Site
 (0.6 away) Contact site
  • 0 views
  • 29 Jun, 2021
  • +24 other locations
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma

btk inhibitor
umbralisib
hodgkin's disease
stem cell transplantation
diffuse large b-cell lymphoma
TG Therapeutics Investigational Trial Site
 (5.1 away) Contact site
  • 0 views
  • 30 Jul, 2021
  • +203 other locations
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.

testosterone
serum testosterone
replacement therapy
testosterone topical
testosterone level
OnSite Clinical Solutions, LLC - Charlotte /ID# 170449
 (0.0 away) Contact site
  • 16879 views
  • 30 Jul, 2021
  • +485 other locations